FDA recall D-0541-2025

Cipla USA, Inc. · Class II · drug

Product

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)

Reason for recall

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Distribution

Distributed Nationwide in the USA

Key facts

Status
Ongoing
Initiation date
2025-06-30
Report date
2025-07-30
Voluntary/Mandated
Voluntary: Firm initiated
Location
Warren, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0541-2025